MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.930
+0.075 (2.63%)
Jun 3, 2026, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €53.8 million as of June 3, 2026. Its market cap has decreased by -31.18% in one year.
Market Cap
53.80M
Enterprise Value
46.37M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.93
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 53.80M, a decrease of -59.47%. That is a compound annual growth rate of -17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 55.21M | -28.73% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 146.94M |
| ABIONYX Pharma | 98.82M |
| Valerio Therapeutics Société anonyme | 95.79M |
| Adocia | 94.32M |
| OSE Immunotherapeutics | 93.67M |
| THX Pharma Société Anonyme | 48.98M |
| Fermentalg | 43.96M |
| Nicox | 33.14M |